BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36399071)

  • 1. Kruppel-like factor 1-GATA1 fusion protein improves the sickle cell disease phenotype in mice both in vitro and in vivo.
    Zhu J; Li H; Aerbajinai W; Kumkhaek C; Pirooznia M; Saxena A; Dagur P; Chin K; Rodgers GP
    Blood; 2022 Nov; 140(21):2276-2289. PubMed ID: 36399071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant erythroid Kruppel-like factor fused to GATA1 up-regulates delta- and gamma-globin expression in erythroid cells.
    Zhu J; Chin K; Aerbajinai W; Trainor C; Gao P; Rodgers GP
    Blood; 2011 Mar; 117(11):3045-52. PubMed ID: 21220744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo activation of the human δ-globin gene: the therapeutic potential in β-thalassemic mice.
    Manchinu MF; Marongiu MF; Poddie D; Casu C; Latini V; Simbula M; Galanello R; Moi P; Cao A; Porcu S; Ristaldi MS
    Haematologica; 2014 Jan; 99(1):76-84. PubMed ID: 23872310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-globin gene expression improves sickle cell disease in a humanised mouse model.
    Porcu S; Simbula M; Marongiu MF; Perra A; Poddie D; Perseu L; Kowalik MA; Littera R; Barella S; Caria CA; Demartis FR; Ristaldi MS
    Br J Haematol; 2021 Jun; 193(6):1228-1237. PubMed ID: 34046885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients.
    Breda L; Casu C; Gardenghi S; Bianchi N; Cartegni L; Narla M; Yazdanbakhsh K; Musso M; Manwani D; Little J; Gardner LB; Kleinert DA; Prus E; Fibach E; Grady RW; Giardina PJ; Gambari R; Rivella S
    PLoS One; 2012; 7(3):e32345. PubMed ID: 22479321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of the endogenous
    Boontanrart MY; Mächler E; Ponta S; Nelis JC; Preiano VG; Corn JE
    Elife; 2023 Jun; 12():. PubMed ID: 37265399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation for engraftment of CD34
    Uchida N; Li L; Nassehi T; Drysdale CM; Yapundich M; Gamer J; Haro-Mora JJ; Demirci S; Leonard A; Bonifacino AC; Krouse AE; Linde NS; Allen C; Peshwa MV; De Ravin SS; Donahue RE; Malech HL; Tisdale JF
    Cell Rep Med; 2021 Apr; 2(4):100247. PubMed ID: 33948577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly efficient therapeutic gene editing of human hematopoietic stem cells.
    Wu Y; Zeng J; Roscoe BP; Liu P; Yao Q; Lazzarotto CR; Clement K; Cole MA; Luk K; Baricordi C; Shen AH; Ren C; Esrick EB; Manis JP; Dorfman DM; Williams DA; Biffi A; Brugnara C; Biasco L; Brendel C; Pinello L; Tsai SQ; Wolfe SA; Bauer DE
    Nat Med; 2019 May; 25(5):776-783. PubMed ID: 30911135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells.
    Urbinati F; Hargrove PW; Geiger S; Romero Z; Wherley J; Kaufman ML; Hollis RP; Chambers CB; Persons DA; Kohn DB; Wilber A
    Exp Hematol; 2015 May; 43(5):346-351. PubMed ID: 25681747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study.
    Urbinati F; Campo Fernandez B; Masiuk KE; Poletti V; Hollis RP; Koziol C; Kaufman ML; Brown D; Mavilio F; Kohn DB
    Hum Gene Ther; 2018 Oct; 29(10):1153-1166. PubMed ID: 30198339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes.
    Campbell AD; Cui S; Shi L; Urbonya R; Mathias A; Bradley K; Bonsu KO; Douglas RR; Halford B; Schmidt L; Harro D; Giacherio D; Tanimoto K; Tanabe O; Engel JD
    Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18808-13. PubMed ID: 22042865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells.
    Kurpad C; Mukherjee P; Wang XS; Ponnazhagan S; Li L; Yoder MC; Srivastava A
    J Hematother Stem Cell Res; 1999 Dec; 8(6):585-92. PubMed ID: 10645765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of delta-globin gene expression by erythroid Krupple-like factor: a potential approach for gene therapy of sickle cell disease.
    Donze D; Jeancake PH; Townes TM
    Blood; 1996 Nov; 88(10):4051-7. PubMed ID: 8916973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype.
    Brendel C; Guda S; Renella R; Bauer DE; Canver MC; Kim YJ; Heeney MM; Klatt D; Fogel J; Milsom MD; Orkin SH; Gregory RI; Williams DA
    J Clin Invest; 2016 Oct; 126(10):3868-3878. PubMed ID: 27599293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease.
    Germino-Watnick P; Hinds M; Le A; Chu R; Liu X; Uchida N
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of transcription factors KLF1 and GATA1 on red blood cell antigen expression: a review.
    Lopez GH; Sarri ME; Flower RL; Hyland CA
    Immunohematology; 2024 Apr; 40(1):1-9. PubMed ID: 38739025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A natural regulatory mutation in the proximal promoter elevates fetal
    Martyn GE; Wienert B; Kurita R; Nakamura Y; Quinlan KGR; Crossley M
    Blood; 2019 Feb; 133(8):852-856. PubMed ID: 30617196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTD small phosphatase like 2 (CTDSPL2) can increase ε- and γ-globin gene expression in K562 cells and CD34+ cells derived from umbilical cord blood.
    Ma YN; Zhang X; Yu HC; Zhang JW
    BMC Cell Biol; 2010 Oct; 11():75. PubMed ID: 20932329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenofovir disoproxil fumarate-mediated γ-globin induction is correlated with the suppression of trans-acting factors in CD34
    Khan F; Ali H; Musharraf SG
    Eur J Pharmacol; 2022 Jul; 927():175036. PubMed ID: 35618038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Globin sleeping beauty transposon reduces red blood cell sickling in a patient-derived CD34(+)-based in vitro model.
    Sjeklocha LM; Wong PY; Belcher JD; Vercellotti GM; Steer CJ
    PLoS One; 2013; 8(11):e80403. PubMed ID: 24260386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.